Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11958849 GLS1 inhibitors for treating disease

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

April 25, 2022

Date of Patent

April 16, 2024

Patent Application Number

17660541

Patent Citations

‌

US Patent 9809588 GLS1 inhibitors for treating disease

‌

US Patent 10125128 GLS1 inhibitors for treating disease

‌

US Patent 10150753 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

‌

US Patent 10344025 GLS1 inhibitors for treating disease

‌

US Patent 10722487 Glutaminase inhibitor therapy

‌

US Patent 10738043 GLS1 inhibitors for treating disease

‌

US Patent 10766892 GLS1 inhibitors for treating disease

‌

US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

‌

US Patent 11045443 Glutaminase inhibitor therapy

‌

US Patent 11603365 Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

•••

Patent Inventor Names

Timothy Heffernan

Kang Le

Jay Theroff

Anne Yau

Maria Emilia Di Francesco

Christopher Lawrence Carroll

Gang Liu

Richard Lewis

Timothy McAfoos

Philip Jones

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11958849

Patent Primary Examiner

CPC Code

•••

Find more entities like US Patent 11958849 GLS1 inhibitors for treating disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API